Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s):  CLAZF

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID... see more

TSXV:CLAS.H - Post Discussion

Claritas Pharmaceuticals Inc > RE:Second application
View:
Post by Red~One on Jan 25, 2022 1:17pm

RE:Second application

I wouldn't worry ...too much...... there was no NR to that effect....
Comment by PTBailey on Jan 25, 2022 2:50pm
The reason there was no NR about this is because there is no materail change, I am simply referring to how the process is going and passing along what I read from someone who talked with Bob.
Comment by Red~One on Jan 25, 2022 5:53pm
Heard it from my cousin.... who heard it from a friend.... who read it on a bullboard....sure  you did
Comment by PTBailey on Jan 25, 2022 7:10pm
Sucks not to be outside the loop doesn't it.